HITNasdaqInsurance Agents, Brokers & ServiceFiscal year ends December 31
Health In Tech, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.64−0.02 (-2.58%)
Close on Oct 19, 2026
- Market cap
- $39.90M
- P/E (TTM)
- –
- Dividend yield
- –
Health In Tech, Inc. revenue by segment
By business segment
By product or service
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Revenues from underwriting modeling (ICE) | $5.16M | $5.98M | $6.86M | $7.53M | $7.67M | $7.22M | $6.65M | 15.7% | -32.7% |
| Revenues from fees | – | – | $26.46M | $23.19M | $19.02M | $15.16M | $12.84M | – | – |
By region
From the segment and revenue-disaggregation notes of Health In Tech's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.